Encephabol In The Treatment Of Patients With Moderate Cognitive Disturbances

E.I. Chukanova

Encephabol in the treatment of patients with moderate cognitive disturbances
We conducted the complex study of the efficacy and safety of the drug Encephabol (piritinol) in patients with chronic cerebrovascular insufficiency with mild cognitive impairment. The daily dose was 200 mg thrice daily, course of treatment - 60 days. For the year held two piritinol treatments - for 1st and 6th month of follow-up. Piritinol at a dose of 600 mg daily leads to significant improvement of cognitive function and reduction of asthenic syndrome and depression severity in patients. Piritinol administration causes the decrease of progression rate of chronic cerebrovascular insufficiency. The drug in this dose is well tolerated, including elderly patients groups.

Similar Articles

Бионика Медиа